Live Breaking News & Updates on Cerebral Protection

Stay updated with breaking news from Cerebral protection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial

NEW YORK & AACHEN, Germany, April 02, 2024 Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the enrollment of the first patient in the PROTEMBO Investigational Device Exemption (IDE) Pivotal Trial (NCT05873816). The trial will enroll between 250-500 randomized patients undergoing transcatheter aortic valve replacement (TAVR) in the USA and Europe with the ProtEmbo® System, an innovative next generation cerebral embolic protection devic ....

United States , Roxana Mehran Mount , Conrad Rasmus Karl , Raj Makkar Cedars , Los Angeles , Protembis Gmbh , Stephan Haussig Herzzentrum , Protembis Gmb , Global Co , Study Executive Committee , Boston Scientific , Superiority Trial , Demonstrate Effectiveness Against , Currently Approved Sentinel , Device Exemption , Pivotal Trial , New York Presbyterian Hospital , Cedars Sinai , Global Co Principal Investigators , Mount Sinai , Study Executive , Conrad Rasmus , Cerebral Protection System , Cerebral Protection ,